The Income & Growth VCT plc ("the Company", "the VCT" or "I&G VCT") is a Venture Capital Trust ("VCT") listed on the London Stock Exchange. Its investment portfolio is advised by Mobeus Equity Partners LLP ("Mobeus").
The objective of the Company is to provide investors with an attractive return, by maximising the stream of tax-free dividend distributions from the income and capital gains generated by a diverse and carefully selected portfolio of investments, while continuing at all times to qualify as a VCT.
-
|
Net asset value total return per share was 2.0% for the six months.
|
- |
Share price total return per share was 1.9% for the six months. |
- |
The Board has declared an interim dividend for the current year of 3.00 pence per share to be paid to shareholders on 20 June 2017, which will bring cumulative dividends paid since the inception of the current share class* to 87.50 pence per share. |
- |
The Company made new investments totalling £3.14 million into four companies, BookingTek, Biosite, Tapas Revolution and Buster & Punch. In addition, £0.93 million was invested in Preservica, an existing portfolio company. |
Performance Summary
The table below shows the recent past performance of the Company's current class* of shares for each of the last five years, and the current year to date.
|
|
Net assets
|
NAV per share
|
Share price1
|
Cumulative dividends paid per share |
Cumulative total return per share to shareholders2 |
Dividends paid and proposed in respect of each year |
|
|
(NAV basis) |
(Share price basis) |
||||||
As at |
|
(£m) |
(p) |
(p) |
(p) |
(p) |
(p) |
(p) |
31 March 2017 |
|
69.88 |
96.43 |
86.50 |
84.50 |
180.93 |
171.00 |
3.004 |
30 September 2016 |
70.84 |
98.51 |
88.80 |
80.50 |
179.01 |
169.30 |
10.00 |
|
30 September 2015 |
75.20 |
106.38 |
93.50 |
68.50 |
174.88 |
162.00 |
12.00 |
|
30 September 2014 |
69.31 |
114.60 |
103.503 |
50.50 |
165.10 |
154.00 |
18.00 |
|
30 September 2013 |
60.47 |
113.90 |
99.50 |
40.50 |
154.40 |
140.00 |
10.00 |
|
30 September 2012 |
50.55 |
109.62 |
97.00 |
28.50 |
138.12 |
125.50 |
26.00 |
|
|
|
|
|
|
|
|
|
|
1 Source: Panmure Gordon & Co (mid-price).
2 Cumulative total return per share comprises the NAV per share (NAV basis) or the mid-market price per share (share price basis) plus cumulative dividends paid since launch of the current share class*.
3 The share price at 30 September 2014 has been adjusted to add back the dividend of 8.00 pence per share paid on 30 October 2014, which was excluded from the listed share price at that year end.
4 An interim dividend of 3.00 pence, referred to in the Financial Highlights above, is payable to shareholders on 20 June 2017.
* The first allotment of the former 'S' share class, now the current share class, took place on 6 February 2008.
I am pleased to present the Company's Half-Year Report for the six months ended 31 March 2017.
The half-year has again seen steady progress with a further positive return for the period, which is detailed in the Performance section below, and an increase in the rate of growth capital investments made, in accordance with the amended Investment Policy approved by shareholders in February 2016.
Seven investments have now been completed in accordance with the amended Investment Policy, in response to the new VCT legislation introduced by the Finance (No 2) Act 2015 (the "new VCT Rules"). The main features of this legislation are disclosed in the Summary of VCT Regulations in the Half-Year Report. Five of these seven investments were made in the period under review. Levels of new investment across the VCT industry have been lower than the comparable periods, so the Company has made a relatively strong start to investing under the new VCT rules.
The existing MBO focused portfolio constructed under the previous VCT rules has continued to perform steadily.
Performance
The Company's NAV total return per share was 2.0% for the six months to 31 March 2017 (2016 3.8%) while the total share price return was 1.9% (2016: 7.0%).
Cumulative NAV total return per share (being the closing net asset value plus total dividends paid to date) has risen to180.93 pence compared to 179.01 pence at the year-end. This represents a further increase of 1.1% over the period.
Investment portfolio
The portfolio has performed steadily during the period, increasing in value by 1.5% (2016: 6.5%) on a like-for-like basis. The aggregate portfolio saw a net increase of £0.07 million in realised gains and £0.73 million in unrealised gains over the six month period. The portfolio was valued at £51.90 million at the period-end (30 September 2016: £54.36 million).
During the six months under review, the Company invested a total of £ 4.07 million (including £0.72 million via a company preparing to trade), (2016: £4.47 million, including £4.18 million via companies preparing to trade) into five (2016: three) investments. These were BookingTek, a company that has developed a real-time booking platform for hotel meeting rooms and restaurant reservations; Biosite, a fast growing provider of biometric access control and software-based workforce management solutions for the construction sector; Preservica, an existing portfolio company which has developed software to preserve past and current data for future retrieval; Tapas Revolution, a leading Spanish themed restaurant chain; and most recently, Buster & Punch, a contemporary interiors brand.
The Company received cash proceeds of £6.61 million during the six month period, mostly being partial loan stock repayments.
Details of all these transactions and the performance of the portfolio are contained in the Investment Review.
Revenue account
The results for the period are set out in the Unaudited Condensed Income Statement in the Half-Year Report and show a revenue return (after tax) of 1.42 pence per share (2016: 1.69 pence). The revenue return for the period of £1.02 million has fallen from last year's comparable figure of £1.19 million. This fall is mainly due to a large interest receipt arising from the exit of Original Additions, which was included in the 2016 figure. Ignoring the effect of this non-recurring income, the underlying loan stock interest fell only slightly, which highlights the resilience of the income from the current portfolio.
Dividends
The Board continues to be committed to providing an attractive dividend stream to shareholders and is pleased to declare an interim dividend of 3.00 pence per share for the year ending 30 September 2017, comprising 1.50 pence of income and 1.50 pence of capital. This dividend will be paid on 20 June 2017 to shareholders on the Register on 26 May 2017 and will bring cumulative dividends per share paid to date to 87.50 pence.
In respect of the past five financial years, and this half-year, the Company has now paid or declared dividends totalling 79.00 pence per share.
Shareholders are encouraged to ensure that Capita, the Company's Registrar, has up-to-date details for them and to check whether they have received all dividends payable to them. This is particularly important if they have recently moved house or changed their bank account. We are aware that a number of dividends remain unclaimed by shareholders and whilst we will continue to endeavour to contact you if this is the case, we cannot guarantee that we will be able to do so if the Registrars do not have an up-to-date address and/or email address for you.
Dividend Investment Scheme
The Company's Dividend Investment Scheme ("the Scheme") is a convenient, easy and cost effective way for shareholders to build up their shareholding in the Company. Instead of receiving cash dividends, shareholders can elect to receive new shares in the Company. By opting to receive a dividend in this manner, there are three benefits to shareholders:
- The dividend remains tax free;
- Shareholders are allotted new shares in the Company which will, subject to their particular circumstances, attract VCT tax reliefs applicable for the tax year in which the shares are allotted. The tax relief currently available to investors in new VCT shares is 30% for the 2017/18 tax year for investments up to £200,000 in any one tax year; and
- The Scheme also has one particular advantage. Under its terms, a member is able to re-invest at an advantageous price, being the average market price of the shares for the five business days prior to the dividend being paid. This price is likely to be at a discount of 10% to the underlying net asset value (provided that this is greater than 70% of the latest published net asset value per share).
Shareholders wishing to join the Scheme should submit a mandate form to Capita Asset Services, the Scheme Administrator, by no later than Monday, 5 June 2017, to ensure that they receive the above dividend as shares. Details of where to obtain an application form can be found in Shareholder Information in the Half-Year Report.
Industry developments
An announcement in the recent Budget has brought VCTs within the remit of the current Patient Capital Review. The review, led by HM Treasury, is considering the current availability of long-term finance for innovative and growing companies looking to expand their businesses and changes in government policy that may support the expansion of long-term capital for growing innovative firms. We are closely monitoring developments and are continuing to support industry bodies such as the Association of Investment Companies, BVCA and EISA who are contributing their views to the Government on the Company's behalf.
A summary of current VCT regulation is included below.
Liquidity
Annual fundraisings by the Company have provided it with a satisfactory level of liquidity sufficient to pursue its Objective and to meet the Company's running costs. The Board will consider additional fundraising in the future in line with its liquidity and new investment requirements, together with an assessment of the effects of possible future legislative changes.
Cash available for investment
The Board continues to monitor credit risk in respect of its cash balances and to prioritise the security and protection of the Company's capital. Cash and liquidity fund balances as at 31 March 2017 amounted to £17.70 million. This figure included £6.74 million held in money market funds with AAA credit ratings and
£10.96 million held in deposit accounts with a number of well-known financial institutions across a range of maturities. In addition, the investment portfolio contained £4.53 million in companies preparing to trade that also hold cash in money market funds.
Share buy-backs
During the six months ended 31 March 2017, the Company bought back 32,790 of its own shares, representing 0.1% (2016: 0.3%) of the shares in issue at the beginning of the period, at a total cost of £0.03 million (2016: £0.21 million) inclusive of expenses.
It is the Company's policy to cancel all shares bought back by the Company. The Board regularly reviews its buyback policy and currently seeks to maintain the discount to NAV at which the Company's shares trade at around 10% below the latest published NAV.
Shareholder communications
May I remind you that the Company has its own website which is available at www.incomeandgrowthvct.co.uk.
The Investment Adviser held its seventh annual Shareholder Event in January 2017 which, from the feedback submitted, was well received by shareholders. The event included presentations on the investment activity and performance of the Mobeus VCTs. I would like to thank those shareholders who attended for helping to make it such a success. The next Event will take place in January 2018. Shareholders will be sent further details and an invitation nearer to the time.
Outlook
The outlook for the UK economy over the next year and the medium-term remains somewhat unclear, although current forecasts still predict economic growth over the next few years for the UK economy. The UK Government will presumably commence formal negotiations for the UK to leave the EU, after the General Election in June. The outcome of these negotiations with the EU will in due course provide more clarity to the UK economic environment.
In the meantime, the Board and Investment Adviser consider that the portfolio is well positioned to withstand this uncertainty. We will continue our measured and cautious approach to investment appraisal and our active engagement with existing portfolio companies. The portfolio has a solid foundation of investments made under the previous MBO strategy, the majority of which are mature and profitable companies providing consistent income returns. Over the coming years, this portfolio mix is expected to change towards younger growth capital companies. These sorts of companies typically exhibit more volatility in returns and generate less income as they tend to re-invest profits during their growth phase. Your Board remains confident that, within the current regulatory environment, and with the Investment Adviser's expanded investment team, attractive opportunities will continue to be identified.
Once again, I would like to take this opportunity to thank all shareholders for their continued support.
Colin Hook
Chairman
16 May 2017
Investment Policy
The Company's policy is to invest primarily in a diverse portfolio of UK unquoted companies. Investments are generally structured as part loan and part equity in order to receive regular income and to generate capital gain upon sale.
Investments are made selectively across a number of sectors, principally in established companies.
The Company's cash and liquid resources are held in a range of instruments of varying maturities, subject to the overriding criterion that the risk of loss of capital be minimised.
VCT regulation
The Investment Policy is designed to ensure that the Company continues to qualify and is approved as a VCT by HMRC.
Amongst other conditions, the Company may not invest more than 15% of its investments (by VCT value at the time of investment) in a single company or group and must have at least 70% by VCT value of its investments throughout the period in shares or securities comprised in VCT qualifying holdings of which a minimum overall of 30% by VCT value (70% for funds raised after 6 April 2011) must be in ordinary shares which carry no preferential rights (save as may be permitted under VCT rules). In addition, although the VCT can invest less than 30% (70% for funds raised after 6 April 2011) of an investment in a specific company in ordinary shares it must have at least 10% by VCT value of its total investments in each VCT qualifying company in ordinary shares which carry no preferential rights (save as may be permitted under VCT rules).
The companies in which investments are made must have no more than £15 million of gross assets at the time of investment and £16 million immediately following the investment to be classed as a VCT qualifying holding.
Asset Mix
The Company initially holds its funds in a portfolio of interest bearing investments and deposits. The investment portfolio of qualifying investments is built up over a three year period with the aim of investing and maintaining at least 70% of net funds raised in qualifying investments.
Risk diversification and maximum exposures
Risk is spread by investing in a number of different businesses across different industry sectors. To reduce the risk of high exposure to equities, each qualifying investment is structured to achieve the optimum balance between loan stock and equity to provide protection against downside risk alongside the best potential overall returns.
Co-investment
The Company is entitled to invest alongside other VCTs advised by Mobeus Equity Partners LLP that have a similar investment policy, normally on a pro rata to net assets basis.
Borrowing
The Company's articles of association permit borrowing of up to 10% of the adjusted capital and reserves (as defined therein). However, it has never borrowed and the Board has currently no plans to undertake any borrowing.
Summary of VCT Regulation
To assist shareholders, the following table contains a summary of the most important rules that determine VCT approval.
To maintain its status as a VCT, the Company must meet a number of conditions, the most important of which are that: - The Company must hold at least 70%, by VCT tax value*, of its total investments (shares, securities and liquidity) in VCT qualifying holdings, within approximately three years of a fundraising; - Of these qualifying holdings, an overall minimum of 70% by VCT tax value* (30% for funds raised on or before 6 April 2011) must be in ordinary shares which carry no preferential rights (save as may be permitted under VCT rules); - No investment in a single company or group of companies may represent more than 15% (by VCT tax value*) of the Company's total investments at the date of investment; The Company must pay sufficient levels of income dividend from its revenue available for distribution so as not to retain more than 15% of its income from shares and securities in a year; - The Company's shares must be listed on a regulated European stock market; and - Non-qualifying investments can no longer be made, except for certain exemptions in managing the Company's short-term liquidity; - To be a VCT qualifying holding, new investments must be in companies:- - which carry on a qualifying trade; - which have no more than £15 million of gross assets at the time of investment and £16 million immediately following investment from VCTs; - whose maximum age is generally seven years (ten years for knowledge intensive businesses); - that receive no more than an annual limit of £5 million and a lifetime limit of £12 million (£20 million for knowledge intensive companies), from VCTs and similar sources of State Aid funding; - that use the funds received from VCTs for growth and development purposes. *VCT tax value means as valued in accordance with prevailing VCT legislation, which may not be the same as the investment cost or the carrying value of the investment shown in the Investment Portfolio Summary in Half-Year Report.
|
A total of £4.07 million was invested into five companies during the six months under review. This comprised new investments into BookingTek, Biosite, Tapas Revolution, Buster & Punch and a further investment into an existing portfolio company, Preservica.
Company
|
Business |
Date of investment |
Amount of new Investment (£m) |
BookingTek |
Direct booking software for hotels |
October 2016 |
0.78 |
Based in London, BookingTek has developed software that enables hotels to reduce their reliance on third-party booking systems by means of a real-time booking platform for meeting rooms and restaurant reservations. The investment is to support further growth. The company's latest accounts for the year ended 31 July 2016 show turnover of £2.03 million and loss before interest, tax and amortisation of goodwill of £0.29 million. |
|||
Biosite |
Workforce management |
November 2016 |
0.86 |
Based in the Midlands, Pattern Analytics (Biosite) is a fast-growing provider of biometric access control and software-based workforce management solutions for the construction sector. The investment will support the expansion of the team to facilitate the development of new site-management tools to enable managers to oversee all aspects of a construction project. The company's latest accounts for the year ended 31 July 2016 show turnover of £4.69 million and profit before interest, tax and amortisation of goodwill of £0.49 million. |
|||
Preservica |
Seller of proprietary digital archiving software |
December 2016 |
0.93 |
Preservica has developed the world's leading software for the long-term preservation of digital records ensuring that digital content remains accessible, irrespective of future changes in technology. Previously a subsidiary of Tessella, it was demerged prior to the sale of Tessella in December 2015. The new investment provided additional growth capital to finance the development of the business. The company's latest accounts for the year ended 31 March 2016 show turnover of £1.78 million and profit before interest, tax and amortisation of goodwill of £0.16 million. |
|||
Tapas Revolution |
Restaurant chain |
January 2017 |
0.78 |
Based in London, Ibericos Etc. (which trades as Tapas Revolution) is a leading Spanish restaurant chain in the casual dining sector focusing on shopping centre sites with high footfall. Having opened its first restaurant in Shepherd's Bush: Westfield, the business has since opened six restaurants. The investment provided growth capital to a high-calibre team with significant restaurant rollout experience who have spent the past five years building and refining their offer and are now well placed to capitalise on a strong pipeline of new sites. The company's latest accounts for the year ended 25 October 2015 show turnover of £2.37 million and loss before interest, tax and amortisation of goodwill of £0.16 million. |
|||
Buster & Punch |
Retailer |
March 2017 |
0.72 |
Chatfield Services Limited (trading as Buster & Punch) is a London-based interiors brand founded in 2012 by architect and industrial designer Massimo Buster Minale. Buster + Punch (www.busterandpunch.com) started in a small garage in East London, where it built the "world's first designer LED light bulb" (Buster Bulb) and made its name with its industrial-inspired lighting. Its products are now sold in over 50 countries, both directly to end-consumers, designers and architects, and through well-known retailers including John Lewis, Harvey Nichols and Harrods. The investment will support the business's international expansion plans and the broadening of its product range. The company's latest accounts for the year ended 31 March 2016 show turnover of £1.98 million and profit before interest, tax and amortisation of goodwill of £0.47 million. |
Realisations in the half-year
There have been no full realisations during the six month period under review although the Company received total cash proceeds of £6.61 million (2016: £10.65 million). This was in the form of loan stock repayments of £6.45 million (2016: £1.75 million) detailed below, deferred consideration of £0.06 million from Focus Pharma and MachineWorks, realised in a previous period, and other receipts of £0.10 million.
Loan stock repayments
Partial loan stock repayments received from seven companies totalled £6.45 million for the six months as summarised below:
|
Company |
Business |
Month(s) |
Amount (£000's) |
|
|
Backhouse Management |
Company preparing to trade |
January |
1,203 |
|
|
Barham Consulting |
Company preparing to trade |
December, March |
1,203 |
|
|
Creasy Marketing |
Company preparing to trade |
March |
1,203 |
|
|
McGrigor Management |
Company preparing to trade |
January, February |
1,203 |
|
|
Hollydale Management |
Company preparing to trade |
March |
932 |
|
|
Chatfield Services |
Company preparing to trade |
March |
687 |
|
|
BG Training |
Technical training |
January |
18 |
|
|
|
|
Total |
6,449 |
|
Total cost at 31 March 2017 (unaudited) £ |
Valuation at 30 September 2016 (audited) £ |
Additional investments in the period £ |
Valuation at 31 March 2017 (unaudited) £ |
|||||
|
|
|
|
|||||
Tovey Management Limited (trading as Access IS) Provider of data capture and scanning hardware |
3,313,932 |
3,532,917 |
- |
3,969,609 |
||||
Virgin Wines Holding Company Limited Online wine retailer |
2,745,503 |
3,706,526 |
- |
3,766,225 |
||||
Entanet Holdings Limited Wholesale communications provider |
3,175,171 |
3,351,685 |
- |
3,408,538 |
||||
Media Business Insight Holdings Limited A publishing and events business focused on the creative production industries |
3,666,556 |
2,980,641 |
- |
3,349,588 |
||||
ASL Technology Holdings Limited Printer and photocopier services |
2,722,106 |
2,870,789 |
- |
2,938,549 |
||||
I-Dox plc Developer and supplier of knowledge management products |
453,881 |
2,833,470 |
- |
2,916,807 |
||||
Manufacturing Services Investment Limited Company seeking to carry on a business in the manufacturing sector |
2,708,100 |
2,708,100 |
- |
2,708,100 |
||||
Gro-Group Holdings Limited Baby sleep products |
2,398,928 |
1,651,824 |
- |
2,080,321 |
||||
Tharstern Group Limited Software based management Information systems for the printing industry |
1,454,278 |
1,777,923 |
- |
1,734,745 |
||||
CGI Creative Graphics International Limited Vinyl graphics to global automotive, recreation vehicle and aerospace markets |
1,943,948 |
1,768,414 |
- |
1,727,786 |
||||
EOTH Limited (trading as Equip Outdoor Technologies) Distributor of branded outdoor equipment and clothing including the Rab and Lowe Alpine brands |
1,383,313 |
1,495,307 |
- |
1,695,321 |
||||
Veritek Global Holdings Limited Maintenance of imaging equipment |
2,289,859 |
2,297,607 |
- |
1,693,780 |
||||
Vian Marketing Limited (trading as Tushingham Sails) Design, manufacture and sale of stand-up paddleboards and windsurfing sails |
1,207,437 |
1,593,103 |
- |
1,663,277 |
||||
Fullfield Limited (trading as Motorclean) Vehicle cleaning and valet services |
1,517,734 |
2,020,433 |
- |
1,559,379 |
||||
RDL Corporation Limited Recruitment consultants within the pharmaceutical, business intelligence and IT sectors |
1,441,667 |
1,409,809 |
- |
1,486,503 |
||||
Redline Worldwide Limited Provider of security services to the aviation industry |
1,129,121 |
1,129,121 |
- |
1,385,757 |
||||
Turner Topco Limited (trading as ATG Media) Publisher and online auction platform operator |
1,529,075 |
1,114,321 |
- |
1,332,895 |
||||
Bourn Bioscience Limited Management of In-vitro fertilisation clinics |
1,610,379 |
1,206,547 |
- |
1,073,275 |
||||
Master Removers Group Limited (formerly Leap New Co Limited (trading as Anthony Ward Thomas, Bishopsgate and Aussie Man & Van)) A specialist logistics, storage and removals business |
682,183 |
878,989 |
- |
971,039 |
||||
Preservica Limited1 Seller of proprietary digital archiving software |
935,000 |
- |
935,000 |
935,000 |
||||
TPSFF Holdings Limited (formerly The Plastic Surgeon Holdings) Supplier of snagging and finishing services to the property sector |
406,169 |
836,215 |
- |
912,459 |
||||
Pattern Analytics Limited (trading as Biosite) Workforce management and security services for the construction industry |
857,014 |
- |
857,014 |
857,014 |
||||
BookingTek Limited Direct booking software for hotels |
779,095 |
- |
779,095 |
779,095 |
||||
|
Ibericos Etc. Limited (trading as Tapas Revolution) Spanish restaurant chain |
776,386 |
- |
776,386 |
776,386 |
|||
|
Chatfield Services Limited (trading as Buster and Punch)2 Industrial inspired lighting and interiors retailer |
725,226 |
1,504,000 |
- |
725,226 |
|||
|
Jablite Holdings Limited Manufacturer of expanded polystyrene products |
498,790 |
1,271,052 |
- |
712,321 |
|||
|
Aquasium Technology Limited Manufacturing and marketing of bespoke electron beam welding and vacuum furnace equipment |
250,000 |
681,377 |
- |
693,301 |
|||
|
MPB Group Limited Online marketplace for used photographic and video equipment |
650,075 |
650,075 |
|
650,075 |
|||
|
Hollydale Management Limited Company seeking to carry on a business in the food sector |
994,560 |
1,554,000 |
- |
621,600 |
|||
|
Omega Diagnostics Group plc In-vitro diagnostics for food intolerance, autoimmune diseases and infectious diseases |
280,026 |
367,511 |
- |
536,682 |
|||
|
Blaze Signs Holdings Limited Manufacturer and installer of signs |
418,281 |
608,241 |
- |
491,102 |
|||
|
Vectair Holdings Limited Designer and distributor of washroom products |
53,400 |
302,340 |
- |
357,543 |
|||
|
Backhouse Management Limited Company seeking to carry on a business in the motor sector |
782,080 |
1,504,000 |
- |
300,800 |
|||
|
Barham Consulting Limited Company seeking to carry on a business in the catering sector |
782,080 |
1,504,000 |
- |
300,800 |
|||
|
Creasy Marketing Services Limited Company seeking to carry on a business in the textile sector |
782,080 |
1,504,000 |
- |
300,800 |
|||
|
McGrigor Management Limited Company seeking to carry on a business in the pharmaceutical sector |
782,080 |
1,504,000 |
- |
300,800 |
|||
|
LightWorks Software Limited Provider of software for CAD and CAM vendors |
20,471 |
61,212 |
- |
73,793 |
|||
|
BG Training Limited Technical training business |
53,125 |
70,833 |
- |
53,125 |
|||
|
Racoon International Holdings Limited Supplier of hair extensions, hair care products and training |
655,851 |
104,999 |
- |
52,500 |
|||
|
Corero Network Security plc Provider of e-business technologies |
600,000 |
9,577 |
- |
4,670 |
|||
|
Oxonica Limited International nanomaterials group |
2,524,527 |
- |
- |
- |
|||
|
NexxtDrive Limited Developer and exploiter of mechanical transmission technologies |
487,014 |
- |
- |
- |
|||
|
CB Imports Group Limited (trading as Country Baskets) Importer and distributor of artificial flowers, floral sundries and home décor products |
175,000 |
- |
- |
- |
|||
|
Biomer Technology Limited Developer of biomaterials for medical devices |
137,170 |
- |
- |
- |
|||
|
Newquay Helicopters (2013) Limited (in creditors' voluntary liquidation) Helicopter service operator |
15,234 |
- |
- |
. |
|||
|
Watchgate Limited Holding company |
1,000 |
- |
- |
- |
|||
|
Total |
52,794,905 |
54,364,958 |
3,347,495 |
51,896,586 |
|||
1 - A further £935,000 was invested into Preservica Limited, adding to the Company's existing shareholding that was received as part of the disposal of Tessella Holdings Limited in December 2015.
2 - £1,504,000 invested in Chatfield Services Limited, a company preparing to trade, was used for the investment into Buster & Punch. This resulted in a net repayment to the Company of £778,774
|
|
Six months ended 31 March 2017 |
Six months ended 31 March 2016 |
Year ended 30 September 2016 |
||||||
|
|
(unaudited) |
(unaudited) |
(audited) |
||||||
|
Notes |
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
|
|
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
Unrealised gains on investments |
9 |
- |
725,815 |
725,815 |
- |
726,630 |
726,630 |
- |
549,889 |
549,889 |
Realised gains on investments |
9 |
- |
69,100 |
69,100 |
- |
2,471,203 |
2,471,203 |
- |
2,506,146 |
2,506,146 |
Income |
4 |
1,640,297 |
- |
1,640,297 |
1,894,754 |
- |
1,894,754 |
3,201,629 |
- |
3,201,629 |
Investment Adviser's fees |
5 |
(197,406) |
(592,219) |
(789,625) |
(213,564) |
(640,692) |
(854,256) |
(419,260) |
(1,257,781) |
(1,677,041) |
Investment Advisers' performance fees |
5 |
- |
- |
- |
- |
(1,134,982) |
(1,134,982) |
- |
(1,140,221) |
(1,140,221) |
Other expenses |
|
(206,829) |
- |
(206,829) |
(197,949) |
- |
(197,949) |
(392,228) |
- |
(392,228) |
Profit on ordinary activities before taxation |
|
1,236,062 |
202,696 |
1,438,758 |
1,483,241 |
1,422,159 |
2,905,400 |
2,390,141 |
658,033 |
3,048,174 |
Taxation on profit on ordinary activities |
6 |
(211,109) |
211,109 |
- |
(288,818) |
288,818 |
- |
(479,600) |
479,600 |
- |
Profit for the period and total comprehensive income |
|
1,024,953 |
413,805 |
1,438,758 |
1,194,423 |
1,710,977 |
2,905,400 |
1,910,541 |
1,137,633 |
3,048,174 |
Basic and diluted earnings per share |
7 |
1.42p |
0.57p |
1.99p |
1.69p |
2.41p |
4.10p |
2.68p |
1.60p |
4.28p |
|
|
31 March 2017 (unaudited) |
31 March 2016 (unaudited) |
30 September 2016 (audited) |
|
Notes |
£ |
£ |
£ |
||
Fixed assets |
|
|
|
|
|
Investments at fair value |
9 |
51,896,586 |
53,954,429 |
54,364,958 |
|
Current assets |
|
|
|
|
|
Debtors and prepayments |
|
455,875 |
532,667 |
304,935 |
|
Current asset investments |
10 |
9,891,458 |
18,395,656 |
15,338,067 |
|
Cash at bank |
10 |
7,805,131 |
2,805,684 |
2,189,856 |
|
|
18,152,464 |
21,734,007 |
17,832,858 |
||
Creditors: amounts falling due within one year |
(167,622) |
(1,377,009) |
(1,357,178) |
||
Net current assets |
17,984,842 |
20,356,998 |
16,475,680 |
||
Net assets |
69,881,428 |
74,311,427 |
70,840,638 |
||
Capital and reserves |
|
|
|
|
|
Called up share capital |
|
724,688 |
711,648 |
719,140 |
|
Capital redemption reserve |
|
12,313 |
11,564 |
11,985 |
|
Share premium reserve |
|
18,809,469 |
17,628,344 |
18,308,887 |
|
Revaluation reserve |
|
5,645,322 |
4,921,137 |
4,744,396 |
|
Special distributable reserve |
|
24,404,104 |
25,448,930 |
24,980,045 |
|
Realised capital reserve |
|
18,129,188 |
23,393,471 |
20,225,980 |
|
Revenue reserve |
|
2,156,344 |
2,196,333 |
1,850,205 |
|
Equity shareholders' funds |
69,881,428 |
74,311,427 |
70,840,638 |
||
Basic and diluted net asset value: |
|
96.43p |
|
|
|
Basic and diluted net asset value per share |
11 |
104.42p |
98.51p |
Unaudited Condensed Statement of Changes in Equity
for the six months ended 31 March 2017
Non-distributable reserves |
|
Distributable reserves |
|
|||||
|
Called up |
Capital |
Share |
Revaluation |
Special |
Realised |
Revenue |
Total |
|
share |
redemption |
premium |
reserve |
distributable |
capital |
reserve |
|
|
capital |
reserve |
reserve |
|
reserve |
reserve |
|
|
|
|
|
|
|
(Note a) |
|
|
|
|
£ |
£ |
£ |
£ |
£ |
£ |
£ |
£ |
At 1 October 2016 |
719,140 |
11,985 |
18,308,887 |
4,744,396 |
24,980,045 |
20,225,980 |
1,850,205 |
70,840,638 |
Comprehensive income for the period |
|
|
|
|
|
|
|
|
Profit/(loss) for the period |
- |
- |
- |
725,815 |
- |
(312,010) |
1,024,953 |
1,438,758 |
Total comprehensive income for the period |
- |
- |
- |
725,815 |
- |
(312,010) |
1,024,953 |
1,438,758 |
Contributions by and distributions to owners |
|
|
|
|
|
|
|
|
Dividends re-invested into new shares |
5,876 |
- |
500,582 |
- |
- |
- |
- |
506,458 |
Shares bought back |
(328) |
328 |
- |
- |
(29,170) |
- |
- |
(29,170) |
Dividends paid |
- |
- |
- |
- |
- |
(2,156,442) |
(718,814) |
(2,875,256) |
Total contributions by and distributions to owners |
5,548 |
328 |
500,582 |
- |
(29,170) |
(2,156,442) |
(718,814) |
(2,397,968) |
Other movements |
|
|
|
|
|
|
|
|
Realised losses transferred to special reserve (note a) |
- |
- |
- |
- |
(546,771) |
546,771 |
- |
- |
Realisation of previously unrealised depreciation |
- |
- |
- |
175,111 |
- |
(175,111) |
- |
- |
Total other movements |
- |
- |
- |
175,111 |
(546,771) |
371,660 |
- |
- |
At 31 March 2017 |
724,688 |
12,313 |
18,809,469 |
5,645,322 |
24,404,104 |
18,129,188 |
2,156,344 |
69,881,428 |
Notes
a) The Special distributable reserve provides the Company with a reserve to fund market purchases of the Company's own shares, to absorb any existing and future losses and for any other corporate purpose.
Unaudited Condensed Statement of Changes in Equity
for the six months ended 31 March 2016
Non-distributable reserves |
|
Distributable reserves |
|
|||||
|
Called up |
Capital |
Share |
Revaluation |
Special |
Realised |
Revenue |
|
|
share |
redemption |
premium |
reserve |
distributable |
capital |
reserve |
|
|
capital |
reserve |
reserve |
|
reserve |
reserve |
|
Total |
At 1 October 2015 |
706,930 |
9,288 |
16,977,902 |
8,997,633 |
27,147,965 |
19,653,747 |
1,708,831 |
75,202,296 |
Comprehensive income for the period |
|
|
|
|
|
|
|
|
Profit for the period |
- |
- |
- |
726,630 |
- |
984,347 |
1,194,423 |
2,905,400 |
Total comprehensive income for the period |
- |
- |
- |
726,630 |
- |
984,347 |
1,194,423 |
2,905,400 |
Contributions by and distributions to owners |
|
|
|
|
|
|
|
|
Dividends re-invested into new shares |
6,994 |
- |
650,442 |
- |
- |
- |
- |
657,436 |
Shares bought back |
(2,276) |
2,276 |
- |
- |
(212,179) |
- |
- |
(212,179) |
Dividends paid |
- |
- |
- |
- |
- |
(3,534,605) |
(706,921) |
(4,241,526) |
Total contributions by and distributions to owners |
4,718 |
2,276 |
650,442 |
- |
(212,179) |
(3,534,605) |
(706,921) |
(3,796,269) |
Other movements |
|
|
|
|
|
|
|
|
Realised losses transferred to special reserve |
- |
- |
- |
- |
(1,486,856) |
1,486,856 |
- |
- |
Realisation of previously unrealised appreciation |
- |
- |
- |
(4,803,126) |
- |
4,803,126 |
- |
- |
Total other movements |
- |
- |
- |
(4,803,126) |
(1,486,856) |
6,289,982 |
- |
- |
At 31 March 2016 |
711,648 |
11,564 |
17,628,344 |
4,921,137 |
25,448,930 |
23,393,471 |
2,196,333 |
74,311,427 |
|
|
Six months ended 31 March 2017 (unaudited) |
Six months ended 31 March 2016 (unaudited) |
Year ended 30 September 2016 (audited) |
|
Notes |
£ |
£ |
£ |
||
Cash flows from operating activities |
|
|
|
|
|
Profit for the financial period |
|
1,438,758 |
2,905,400 |
3,048,174 |
|
Adjustments for: |
|
|
|
|
|
Unrealised gains on investments |
|
(725,815) |
(726,630) |
(549,889) |
|
Realised gains on investments |
|
(69,100) |
(2,471,203) |
(2,506,146) |
|
(Increase)/decrease in debtors |
|
(150,940) |
(150,101) |
77,630 |
|
(Decrease)/increase in creditors |
|
(1,152,217) |
220,474 |
190,471 |
|
Net cash (outflow)/inflow from operating activities |
(659,314) |
(222,060) |
260,240 |
||
Cash flows from investing activities |
|
|
|
|
|
Purchase of investments |
9 |
(3,347,495) |
(285,932) |
(936,007) |
|
Disposal of investments |
9 |
6,610,782 |
10,645,086 |
10,742,834 |
|
Decrease in bank deposits with a maturity over three months |
|
2,028,243 |
1,960,755 |
1,960,755 |
|
Net cash inflow from investing activities |
|
5,291,530 |
12,319,909 |
11,767,582 |
|
Cash flows from financing activities |
|
|
|
|
|
Equity dividends paid |
8 |
(2,368,798) |
(3,584,090) |
(7,160,312) |
|
Purchase of own shares |
|
(66,509) |
(185,476) |
(212,644) |
|
Net cash outflow from financing activities |
(2,435,307) |
(3,769,566) |
(7,372,956) |
||
Net increase in cash and cash equivalents |
|
2,196,909 |
8,328,283 |
4,654,866 |
|
Cash and cash equivalents at start of period |
|
12,347,911 |
7,693,045 |
7,693,045 |
|
Cash and cash equivalents at end of period |
14,544,820 |
16,021,328 |
12,347,911 |
||
Cash and cash equivalents comprise: |
|
|
|
|
|
Cash at bank and in hand |
|
7,805,131 |
2,805,684 |
2,189,856 |
|
Cash equivalents |
|
6,739,689 |
13,215,644 |
10,158,055 |
The notes below form part of these Half-Year Financial Statements.
Notes to the Unaudited Condensed Financial Statements
for the six months ended 31 March 2017
The Income and Growth VCT plc is a public limited company incorporated in England, registration number 4069483. The registered office is 30 Haymarket, London, SW1Y 4EX.
These Financial Statements prepared in accordance with accounting policies consistent with Financial Reporting Standard 102 ("FRS102"), Financial Reporting Standard 104 ("FRS104") - Interim Financial Reporting, with the Companies Act 2006 and the 2014 Statement of Recommended practice, 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('the SORP') (updated in January 2017) issued by the Association of Investment Companies. The Financial Statements have been prepared on the historical cost basis except for the modification to a fair value basis for certain financial instruments as
specified in note 9.
The Half-Year Report has not been audited, nor has it been reviewed by the auditor pursuant to the Financial Reporting
Council's (FRC) guidance on Review of Interim Financial Information.
The Company has elected to apply early the revised disclosure requirements as set out in Amendments to FRS 102 - Fair value hierarchy disclosures, issued in March 2016.
The accounting policies have been applied consistently throughout the period. Full details of principal accounting policies
will be disclosed in the Annual Report, while the policy in respect of investments is included within an outlined box at the
top of note 9 on investments.
|
Six monthsended 31 March 2017 |
Six months ended 31 March 2016 |
Year ended30 September 2016 |
|
(unaudited) |
(unaudited) |
(audited) |
|
£ |
£ |
£ |
Dividends |
180,519 |
39,150 |
114,915 |
Money market funds |
10,951 |
17,595 |
38,412 |
Loan stock interest |
1,412,723 |
1,779,137 |
2,946,909 |
Bank deposit interest |
36,036 |
58,872 |
101,393 |
Other income |
68 |
- |
- |
Total income |
1,640,297 |
1,894,754 |
3,201,629 |
5. Investment Adviser's fees and performance fees
|
Six months ended 31 March 2017 |
Six months ended 31 March 2016 |
Year ended30 September 2016 |
|
(unaudited) |
(unaudited) |
(audited) |
|
£ |
£ |
£ |
Allocation to revenue return: Investment Adviser's fees |
197,406 |
213,564 |
419,260 |
Allocation to capital return: Investment Adviser's fees |
592,219 |
640,692 |
1,257,781 |
Investment Advisers' performance fees |
- |
1,134,982 |
1,140,221 |
Total |
789,625 |
1,989,238 |
2,817,262 |
|
|
|
|
Investment Adviser's fees |
789,625 |
854,256 |
1,677,041 |
Investment Advisers' performance fees |
- |
1,134,982 |
1,140,221 |
Total |
789,625 |
1,989,238 |
2,817,262 |
The Directors have charged 75% of the fees payable under the Investment Adviser's agreement, and 100% of the amounts payable under the Incentive Agreements, to the capital reserve. The Directors believe it is appropriate to charge the incentive
fees wholly against the capital return, as any fees payable depend on capital performance, as explained below.
On 30 September 2014, a new incentive fee agreement was signed between the Board and Mobeus, with effect from 1 October 2013, to amend and replace the previous agreement. The previous agreement remains in force, but only
with the former adviser, Foresight. For the period ended 31 March 2017, no amount has been accrued under the previous
agreement. Mobeus waived their right to their portion of the fee under the previous agreement. This agreement is due to
expire on 10 March 2019.
Any payment under the new incentive agreement is now 15% of net realised gains for each year, payable in cash. It is
payable only if Cumulative Net Asset Value (NAV) total return per share (being the closing NAV at a year end plus cumulative
dividends paid to that year end, since 1 October 2013 equals or exceeds a "Target Return". The Target Return is the greater of
two targets, being either:
i. compound growth of 6% per annum (but 5% per annum for the year ended 30 September 2014 only), before deducting any incentive fee payable (for the year of calculation only) under both this amended agreement and the existing incentive agreement with Foresight in Cumulative NAV total return per share; or
ii. the cumulative percentage change in the Consumer Prices Index since 1 October 2013 to the relevant
financial year end, theresultant figure then being multiplied by (100+A)/100, where A is the number of full
12 month periods (or part thereof ) that have passed between 1 October 2013 and the relevant financial year end.
Both measures of Target Return are applied to the same opening base, being NAV per share as at 30 September 2013 of
113.90 pence. The objective of this Target Return is to enable shareholders to benefit from a cumulative NAV return of at
least 6% per annum (5% in the financial year ended 30 September 2014), before any incentive fee is payable. Once a
payment has been made, cumulative NAV total return is calculated after deducting past years' incentive fees paid and
payable.
Under this new incentive agreement, any fee payments to Mobeus are subject to an annual cap of an amount equal to 2%
of the net assets of I&G VCT as at the immediately preceding year end. This cap will include any fee payable to Foresight
under the old agreement, although any such payment to Foresight is not capped. Any excess over the 2% remains payable
to Mobeus in the following year(s), subject to the 2% annual cap in such subsequent year(s) and after any
payment in respect of such subsequent year(s).
For the year ending 30 September 2017, the Target Return will be 142.44p per share (being a 6% uplift on the Target Return
at the previous year end of 134.38 pence per share). As at 31 March 2017, the Cumulative Total NAV return is 140.43p per
share, so the Target Return for the 2017 financial year has currently not been met and so no fee has been accrued.
There is no tax charge for the period as the Company has tax losses brought forward from previous periods, which can be
offset against taxable income.
Dividend |
Type |
For the year ended 30 September |
Pence per share |
Date paid |
Six months ended 31 March 2017 (unaudited) |
Six months ended 31 March 2016 (unaudited) |
Year ended 30 September 2016 (audited) |
|
|
||||||
|
|
||||||
|
|
|
|
£ |
£ |
£ |
|
Final |
Income |
2015 |
1.00p |
15 February 2016 |
- |
706,921 |
706,921 |
Final |
Capital |
2015 |
5.00p |
15 February 2016 |
- |
3,534,605 |
3,534,606 |
Interim |
Income |
2016 |
1.00p |
7 July 2016 |
- |
- |
1,067,478 |
Interim |
Capital |
2016 |
5.00p |
7 July 2016 |
- |
- |
3,202,433 |
Final |
Income |
2016 |
1.00p |
15 February 2017 |
718,814 |
- |
- |
Final |
Capital |
2016 |
3.00p |
15 February 2017 |
2,156,442 |
- |
- |
Previous dividends not claimed within the statutory period |
|
|
(5,232) |
||||
|
2,875,256 |
4,241,526 |
8,506,206 |
|
Six months ended 31 March 2017 |
Six months ended 31 March 2016 |
Year ended30 September 2016 |
|
(unaudited) |
(unaudited) |
(audited) |
|
£ |
£ |
£ |
i) Total earnings after taxation: |
1,438,758 |
2,905,400 |
3,048,174 |
Basic and diluted earnings per share |
1.99p |
4.10p |
4.28p |
ii) Net revenue from ordinary activities after taxation |
1,024,953 |
1,194,423 |
1,910,541 |
Basic and diluted revenue return per share |
1.42p |
1.69p |
2.68p |
Net unrealised capital gains on investments |
725,815 |
726,630 |
549,889 |
Net realised capital gains on investments |
69,100 |
2,471,203 |
2,506,146 |
Capital Investment Adviser's fees less taxation |
(381,110) |
(351,874) |
(778,181) |
Investment Advisers' performance fees |
- |
(1,134,982) |
(1,140,221) |
iii) Total capital return |
413,805 |
1,710,977 |
1,137,633 |
Basic and diluted capital return per share |
0.57p |
2.41p |
1.60p |
iv) Weighted average number of shares in issue in the period |
72,037,688 |
70,863,747 |
71,198,046 |
8. Dividends paid
* - £2,875,256 (31 March 2016: £4,241,526; 30 September 2016: £8,506,206) disclosed above differs to that shown in the Statement
of Cash Flows of £2,368,798 (31 March 2016: £3,584,090; 30 September 2016: £7,160,312) due to £506,458 (31 March 2016:
£657,436; 30 September 2016: £1,345,894) of new shares issued as part of the Company's Dividend Investment Scheme.
The most critical estimates, assumptions and judgements relate to the determination of the carrying value of investments at 'fair value through profit and loss' ("FVTPL"). All investments held by the Company are classified as FVTPL, and measured in accordance with the International Private Equity and Venture Capital Valuation ("IPEV") guidelines, as updated in December 2015. This classification is followed as the Company's business is to invest in financial assets with a view to profiting from their total return in the form of capital growth and income.
For investments actively traded in organised financial markets, fair value is generally determined by reference to Stock Exchange market quoted bid prices at the close of business on the balance sheet date. Purchases and sales of quoted investments are recognised on the trade date where a contract of sale exists whose terms require delivery within a time frame determined by the relevant market. Purchases and sales of unlisted investments are recognised when the contract for acquisition or sale becomes unconditional.
Unquoted investments are stated at fair value by the Directors in accordance with the following rules, which are consistent with the IPEV guidelines:
All investments are held at the price of a recent investment for an appropriate period where there is considered to have been no change in fair value. Where such a basis is no longer considered appropriate, each investment is considered as a whole on a 'unit of account' basis alongside consideration of:
i) Where a value is indicated by a material arms-length transaction by an independent third party in the shares of a company, this value will be used.
ii) In the absence of i), and depending upon both the subsequent trading performance and investment structure of an investee company, the valuation basis will usually move to either:-
a) an earnings multiple basis. The shares may be valued by applying a suitable price-earnings ratio to that company's historic, current or forecast post-tax earnings before interest and amortisation (the ratio used being based on a comparable sector but the resulting value being adjusted to reflect points of difference identified by the Investment Adviser compared to the sector including, inter alia, a lack of marketability).
or:-
b) where a company's underperformance against plan indicates a diminution in the value of the investment, provision against cost is made, as appropriate.
iii) Premiums, to the extent that they are considered capital in nature, and that will be received upon repayment of loan stock investments are accrued at fair value when the Company receives the right to the premium and when considered recoverable.
iv) Where an earnings multiple or cost less impairment basis is not appropriate and overriding factors apply, discounted cash flow or net asset valuation bases may be applied.
Capital gains and losses on investments, whether realised or unrealised, are dealt with in the profit and loss and revaluation reserves and movements in the period are shown in the Income Statement.
All investments are initially recognised and subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.
A key judgement made in applying the above accounting policy relates to investments that are permanently impaired. Where the value of an investment has fallen permanently below cost, the loss is treated as a permanent impairment and as a realised loss, even though the investment is still held. The Board assesses the portfolio for such investments and, after agreement with the Investment Adviser, will agree the values that represent the extent to which an investment has become realised. This is based upon an assessment of objective evidence of that investment's future prospects, to determine whether there is potential for the investment to recover in value.
The methods of fair value measurement are classified in to hierarchy based on the reliability of the information used to determine the valuation.
- Level 1 - Fair value is measured based on quoted prices in an active market. - Level 2 - Fair value is measured based on directly observable current market prices or indirectly being derived from market prices. Level 3 - Fair value is measured using valuation techniques using inputs that are not based on observable market data.
|
|
Traded on AIM
Level 1 |
Unquoted ordinary shares Level 3 |
Unquoted Preference shares Level 3 |
Unquoted Loan stock
Level 3 |
Total |
|
£ |
£ |
£ |
£ |
£ |
|
|
|
|
|
|
Valuation at 1 October 2016 |
3,210,558 |
12,137,532 |
22,646 |
38,994,222 |
54,364,958 |
Purchases at cost |
- |
2,943,504 |
- |
403,991 |
3,347,495 |
Sales - proceeds |
- |
(160,584) |
- |
(6,450,198) |
(6,610,782) |
- realised (losses)/gains |
- |
(2,228,980) |
- |
2,298,080 |
69,100 |
Reclassification at valuation |
- |
(87) |
87 |
- |
- |
Unrealised gains/(losses) on investments in the period |
247,601 |
(581,951) |
391,878 |
668,287 |
725,815 |
Valuation at 31 March 2017 |
3,458,159 |
12,109,434 |
414,611 |
35,914,382 |
51,896,586 |
Book cost at 31 March 2017 |
1,333,907 |
20,789,093 |
27,428 |
30,644,477 |
52,794,905 |
Unrealised gains/(losses) at 31 March 2017 |
2,124,252 |
(2,186,018) |
387,183 |
5,269,905 |
5,595,322 |
Permanent impairment of valuation of investments |
- |
(6,493,641) |
- |
- |
(6,493,641) |
Valuation at 31 March 2017 |
3,458,159 |
12,109,434 |
414,611 |
35,914,382 |
51,896,586 |
Gains/(losses) on investments |
|
|
|
|
|
Realised (losses)/gains based on historical cost |
- |
(2,404,091) |
- |
2,298,080 |
(106,011) |
Less amounts recognised as unrealised losses in previous years |
- |
175,111 |
- |
- |
175,111 |
Realised (losses)/gains based on carrying value at 30 September 2016 |
- |
(2,228,980) |
- |
2,298,080 |
69,100 |
Net movement in unrealised gains/ (losses) in the period |
247,601 |
(581,951) |
391,878 |
668,287 |
725,815 |
Gains/(losses) on investments for the period ended 31 March 2017 |
247,601 |
(2,810,931) |
391,878 |
2,966,367 |
794,915 |
Unrealised gains/(losses) at 31 March 2017 above of £5,595,322 differ to that shown in the Revaluation reserve on the Statement of Changes in Equity of £5,645,322. The difference of £50,000 is the estimated fair value of contingent consideration held at the Balance Sheet date, and is included within Debtors.
There has been no significant change in the risk analysis as disclosed in Note 16 of the Financial Statements in the Company's Annual Report. The increase in unrealised valuations of the loan stock investments above reflect the changes in the entitlement to loan premiums, and/or in the underlying enterprise value of the investee company. The increase does not arise from assessments of credit or market risk upon these instruments.
Level 3 unquoted equity and loan investments are valued in accordance with IPEV guidelines as follows:
|
as at31 March 2017 |
as at31 March 2016 |
as at30 September 2016 |
|
(unaudited) |
(unaudited) |
(audited) |
|
£ |
£ |
£ |
Valuation methodology |
|
|
|
Estimated realisation proceeds |
53,125 |
103,917 |
70,833 |
Recent investment price |
9,308,196 |
17,537,589 |
13,666,295 |
Earnings multiple |
39,077,106 |
33,873,159 |
37,417,272 |
Total |
48,438,427 |
51,514,665 |
51,154,400 |
10. Current asset investments
|
as at31 March 2017 |
as at31 March 2016 |
as at30 September 2016 |
|
(unaudited) |
(unaudited) |
(audited) |
|
£ |
£ |
£ |
OEIC Money market funds |
6,739,689 |
10,704,092 |
10,158,055 |
Bank deposits that mature within three months but are not immediately repayable |
- |
2,511,552 |
- |
Cash equivalents per Statement of Cash Flows |
6,739,689 |
13,215,644 |
10,158,055 |
Bank deposits that mature after three months |
3,151,769 |
5,180,012 |
5,180,012 |
Current asset investments |
9,891,458 |
18,395,656 |
15,338,067 |
Cash at bank |
7,805,131 |
2,805,684 |
2,189,856 |
11. Net asset value per share
|
as at31 March 2017 |
as at31 March 2016 |
as at30 September 2016 |
|
(unaudited) |
(unaudited) |
(audited) |
Net assets |
£69,881,428 |
£74,311,427 |
£70,840,638 |
Number of shares in issue |
72,468,771 |
71,164,788 |
71,914,023 |
Net asset value per share - basic and diluted |
96.43p |
104.42p |
98.51p |
12. Post balance sheet events
On 3 May 2017, TPSFF Holding Limited (formerly The Plastic Surgeon Holdings Limited) repaid loan stock of £36,852.
The financial information for the six months ended 31 March 2017 and the six months ended 31 March 2016 has not been audited.
The financial information contained in this Half-Year report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Financial Statements for the year ended 30 September 2016 have been filed with the Registrar of Companies. The auditor has reported on these Financial Statements and that report was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.
Copies of this statement are being sent to all shareholders. Further copies are available free of charge from the Company's registered office, 30 Haymarket, London, SW1Y 4EX, or can be downloaded via the Company's website at www.incomeandgrowthvct.co.uk.
Contact details for further enquiries:
Rob Brittain or Sarah Penfold at Mobeus Equity Partners LLP (the Company Secretary) on 020 7024 7600 or by e-mail on vcts@mobeusequity.co.uk.
Mobeus Equity Partners LLP (the Investment Adviser), on 020 7024 7600 or by e-mail on info@mobeusequity.co.uk.
DISCLAIMER
Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.